摘要 |
Benzenesulfone compounds represented by general formula (I) or pharmaceutically acceptable salts thereof, useful as pharmaceuticals having a combination of leucotriene antagonism with thromboxane A2 antagonism and good oral absorbability, especially as agents for preventing and treating diseases and which leucotriene and thromboxane A2 participate, such as bronchial asthma, wherein B represents an optionally substituted quinolyl group; D represents an optionally substituted phenyl group; E represents a group represented by formulas (a), (b), or (c); one of A<1> and A<2> represents an optionally substituted methylene group or an optionally substituted ethylene group with the other representing a single bond, an optionally substituted methylene group, or an optionally substituted ethylene group, provided that when 1 is 1 and Y represents an optionally substituted phenylene group, each of A<1> and A<2> may represent a single bond; X represents an oxygen atom or a sulfur atom; Y represents an optionally substituted phenylene group, an optionally substituted phenyleneoxy group, or an optionally substituted spirocyclopropinyl group; Z represents a group represented by the formula: -CH=CH-, -CH2-CH2-, -CH2O-, or -O-CH2-; R represents a carboxyl group or tetrazolyl group which may be optionally substituted with an ester residue; 1, n, p, and q, which may be the same or different, are each 0 or 1; and m represents 1, 2, or 3.
|
申请人 |
YAMANOUCHI PHARMACEUTICAL CO., LTD.;YOKOTA, MASAKI;KAWAZOE, SOUICHIROU;OKAMOTO, YOSHINORI;KUBOTA, HIROKAZU;NAITO, RYO;ARAKIDA, YASUHITO |
发明人 |
YOKOTA, MASAKI;KAWAZOE, SOUICHIROU;OKAMOTO, YOSHINORI;KUBOTA, HIROKAZU;NAITO, RYO;ARAKIDA, YASUHITO |